Dexras1 blocks receptor-mediated heterologous sensitization of adenylyl cyclase 1

Area of Science:

• Molecular Biology
• Cell Signaling
• Neuropharmacology

Background:

• Dexras1 (RasD1) is a Ras superfamily G protein implicated in disrupting receptor-G protein signaling.
• Dopamine D(2L) receptors are key regulators of cellular signaling pathways, including adenylyl cyclase (AC) activity and ERK 1/2 activation.

Purpose of the Study:

• To investigate the role of Dexras1 in modulating dopamine D(2L) receptor signaling.
• To determine if Dexras1 affects D(2L) receptor-mediated inhibition of adenylyl cyclase type 1 (AC1) or activation of ERK 1/2.
• To elucidate the mechanism by which Dexras1 influences AC1 sensitization.

Main Methods:

• HEK293 cells expressing dopamine D(2L) receptors were treated with Dexras1.
• Adenylyl cyclase activity was measured under basal and stimulated conditions (A23187).
• ERK 1/2 activation and AC1 sensitization were assessed in the presence and absence of Dexras1 and its mutant (Dexras1G31V).
• Gbetagamma dependence was confirmed using betaARK-ct.

Main Results:

• Dexras1 did not alter acute D(2L) receptor-mediated inhibition of AC1 activity.
• Dexras1 significantly blocked acute D(2L) receptor-mediated activation of ERK 1/2 by approximately 50%.
• Dexras1 completely blocked heterologous sensitization of AC1 induced by persistent D(2L) receptor activation in a concentration-dependent manner.
• The inhibitory effect of Dexras1 on sensitization was dependent on its nucleotide-binding function, as the Dexras1G31V mutant did not block sensitization.
• AC1 sensitization was confirmed to be Gbetagamma-dependent.

Conclusions:

• Dexras1 selectively regulates specific receptor-mediated G protein signaling pathways.
• Dexras1 plays a critical role in inhibiting Gbetagamma-dependent signaling, particularly in the context of receptor-induced AC1 sensitization.
• These findings highlight Dexras1 as a potential modulator of dopamine receptor signaling cascades.